138
Views
0
CrossRef citations to date
0
Altmetric
Editorials

The rise of innovative clinical trial designs: what’s in it for amyotrophic lateral sclerosis?

&
Pages 3-4 | Received 08 Oct 2019, Accepted 13 Oct 2019, Published online: 29 Oct 2019
 
This article responds to:
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis

Declaration of interest

The authors declare that they have no conflict of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 478.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.